Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells 126 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 126 shares of the firm’s stock in a transaction that occurred on Thursday, January 29th. The shares were sold at an average price of $520.02, for a total value of $65,522.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The stock was sold at an average price of $532.61, for a total value of $122,500.30.
• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The shares were sold at an average price of $559.90, for a total value of $58,229.60.
• On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00.

Intuitive Surgical Stock Down 0.7%

Intuitive Surgical stock traded down $3.33 during midday trading on Friday, hitting $504.22. 1,698,254 shares of the stock were exchanged, compared to its average volume of 2,000,962. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $609.08. The business’s 50-day moving average price is $558.64 and its 200-day moving average price is $511.63. The stock has a market capitalization of $180.75 billion, a price-to-earnings ratio of 63.91, a price-to-earnings-growth ratio of 3.92 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period last year, the company posted $2.21 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. The Goldman Sachs Group reissued a “buy” rating and issued a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Rothschild & Co Redburn upped their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Citigroup reissued a “neutral” rating and issued a $590.00 price target (down previously from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $620.41.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently added to or reduced their stakes in the business. Tobam boosted its stake in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. lifted its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the period. Kilter Group LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $27,000. Finally, Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $27,000. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.